Received Aug 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
began seizing; Felt dizzy; fell backward; hit head; This serious case was reported by a other health professional and described the occurrence of seizure in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On 13-AUG-2025, the patient received Menveo. On 13-AUG-2025, less than a day after receiving Menveo, the patient experienced seizure (Verbatim: began seizing) (serious criteria hospitalization and GSK medically significant), dizziness (Verbatim: Felt dizzy) (serious criteria hospitalization), fall (Verbatim: fell backward) (serious criteria hospitalization) and head injury (Verbatim: hit head) (serious criteria hospitalization). On 14-AUG-2025, the outcome of the seizure, dizziness, fall and head injury were resolved (duration 1 day). It was unknown if the reporter considered the seizure, dizziness, fall and head injury to be related to Menveo. The company considered the seizure, dizziness, fall and head injury to be unrelated to Menveo. Additional Information: GSK Receipt Date: 15-AUG-2025 Patient was in hospital for felt dizzy, felt backwards, hit head, began seizing.; Sender's Comments: A case of Seizure, Dizziness, Fall, Head injury, less than a day after receiving Menveo in a 17-year-old male patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Further follow up information has been sought.